Areas of Expertise

---

Industry Briefings

---

Industry Reviews

---

ScientiaNET

---

Medical Devices

Innovative medical devices are enabling critical advances in healthcare delivery.

Novel medical devices, combining therapeutic benefits with breakthrough delivery techniques, are disrupting existing markets and creating new opportunities. Scientia helps clients leverage these opportunities to drive future growth and achieve competitive leadership.

Industry Briefings

December 27, 2011
Managing the Diabetes Epidemic
Patrick Terry

October 06, 2011
Achieving the Holy Grail of T1DM Treatment
John McNamara

September 18, 2009
US Neurostimulation Market:
An Industry Commentary
Scientia Advisors

---

Related Blog Posts

February 22, 2012
More InVitro Diagnostics Acquisitions Ahead: Non-traditional Companies are Entering the IVD Business

February 6, 2012
"Big Data" will begin improving the bottom line of healthcare players

---

Industry Reviews

February 02, 2011
Opportunities in Vascular Devices: New Developments to Change the Treatment Paradigm and Drive Growth

March 25, 2010
Promising Opportunities within the Home Health Management Landscape

October 27, 2009
Strategic Growth Opportunities in Parenteral Drug Delivery:
Where Will Healthcare Decentralization Drive Parenterals Next?

---

Scientia in the News

February 10, 2012
Pharmalot interview with Jonathan Pan on Biosimilar Guidance

February 02, 2012
GEN quotes Harry Glorikian in article: "Collaborations Hold the Potential to Reinvent Drug Development"

January 03, 2012
Harry Glorikian interviewed by partneringNEWS in "partnering spotlight"

---

Press Releases

February 06, 2012
Scientia Advisors Announces Meghan Needham as Director of Marketing

January 31, 2012
Scientia Advisors Announces Rick Lifsitz has joined the firm as a Principal

January 23, 2012
Joslin Diabetes Center and Scientia Advisors Announce Strategic Marketing Agreement